4D Molecular Therapeutics, Inc. Common Stock FDMT
$15.59
+1.30%
at last close
Financials (TTM)
- Revenue
- $92.01 million
- Net Income
- $-179,175,000
- Net Margin
- -194.74%
- Return on Equity
- -43.95%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.09
- Price / Sales
- 9.24
Over the trailing twelve months, 4D Molecular Therapeutics, Inc. Common Stock generated revenue of $92.01 million and net income of $-179,175,000, a net margin of -194.74%.
At the last closing price of $15.59, FDMT trades at 9.24 times sales, with a market capitalization of $850.21 million.
Key Stats
- Last Close
- $15.59
- Market Cap
- $850.21 million
- 52-Week Range
- $4.14 – $16.93
- Average Volume
- 875K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.